Download Lecture 2

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Biosimilar wikipedia , lookup

Orphan drug wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Stimulant wikipedia , lookup

Compounding wikipedia , lookup

Nicotinic agonist wikipedia , lookup

Bad Pharma wikipedia , lookup

Plateau principle wikipedia , lookup

Pharmacognosy wikipedia , lookup

Bilastine wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Medication wikipedia , lookup

Drug discovery wikipedia , lookup

Psychopharmacology wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Prescription costs wikipedia , lookup

Prescription drug prices in the United States wikipedia , lookup

Drug design wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Theralizumab wikipedia , lookup

Drug interaction wikipedia , lookup

Neuropharmacology wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Transcript
Definitions
• Pharmacokinetics
– The process by which a drug is administered,
absorbed, distributed, bound, inactivated,
metabolized and eliminated by the body
• Pharmacodynamics
– The interactions of a drug and the receptors responsible
for its action in the body and CNS
Drug Administration
• Orally (swallowed)
• through Mucus Membranes
– Oral Mucosa (e.g. sublingual)
– Nasal Mucosa (e.g. insufflated)
• Rectally (suppository)
Drug Administration (cont.)
• Parenterally (injection)
– Intravenous (IV)
– Intramuscular (IM)
– Subcutaneous (SC)
– Intraperitoneal (IP)
• Inhaled (through lungs)
Drug Administration (cont.)
• Topical/Transdermal (through skin)
• Directly into CNS
– Intracranial or intracerebral (into brain
tissue)
– Intracerebroventricular (into brain
ventricles)
Drug Administration Summary
• Pharmacokinetics relates
to bioavailability
– The fraction of an
administered dose of a drug
that reaches the blood
stream
• How quickly a drug
reaches its site of action
relates to “addictiveness.”
Distribution: Solubility
• Water-soluble
– Ionized (have electrical charge)
– Crosses through pores in capillaries, but not cell membranes
– The extent of ionization of a drug is expresses as the pKa of the
drug
• Lipid(fat)-soluble
– Non-ionized (no electrical charge)
– Crosses pores, cell membranes, blood-brain-barrier
Distribution: Blood Brain Barrier
Depot Binding
• Drugs bind to “depot sites” or “silent receptors”
• Deposits slow elimination, can increase drug detection
window
Metabolism & Elimination
• Liver
– Enzymes transform drugs
into more water-soluble
metabolites
• Kidneys
– Traps water-soluble
compounds for elimination
via urine
Metabolism and Elimination (cont.)
• Half-lives and Kinetics
– Half-life:
• Plasma half-life: Time it takes for plasma concentration of a
drug to drop by 50%.
• Whole body half-life: Time it takes to eliminate half of the
body content of a drug.
– Factors affecting half-life
•
•
•
•
age
renal excretion
liver metabolism
protein binding
First order kinetics
A constant fraction of drug is eliminated per unit of time.
When drug concentration is high, rate of disappearance
is high.
Zero order kinetics
Rate of elimination is constant.
Rate of elimination is independent of drug concentration.
Constant amount eliminated per unit of time.
Example: Alcohol
The Dose-Response Curve
• X-axis = Dose
• Y-axis = Response, measured as either
– magnitude of response in individual
– number/percentage of individuals responding at a given level
Therapeutic Index
• ED50 = dose at which 50% population shows response
• LD50 =dose at which 50% population dies
• TI = LD50/ED50, an indication of safety of a drug (higher is better)
Potency
• Relative strength of response for a given dose
– accessability, affinity, and efficacy
• D-R curve shifts left with greater potency
Efficacy
(% of maximal change elicited)
• Maximum possible effect
• Indicated by peak of D-R curve
Tolerance
(desensitization)
• Decreased response to same dose
with repeated exposure
• or more drug needed to achieve
same effect
• Right-ward shift of D-R curve
• Sometimes occurs in an acute
dose (e.g. alcohol)
• Can develop across drugs (crosstolerance)
• Caused by compensatory
mechanisms that oppose the
effects of the drug
Tolerance
• Physical
– User requires more of the drug to achieve the same
effect, and the same amount will produce a lesser effect.
• Psychological
– As the user becomes familiar with the drug’s effects,
s/he learns tricks to hide or counteract the effects.
• Metabolic
– The user is able to break down and/or excrete the drug
more quickly due to repeated exposure.
Sensitization
• Increased response to same dose
with repeated exposure
• or less drug needed to achieve
same effect
• Left-ward shift in D-R curve
• Sometimes occurs in an acute
dose (e.g. amphetamine)
• Can develop across drugs (crosssensitization)
Mechanisms of Tolerance and Sensitization
• Pharmacokinetic
– changes in drug availability at site of action; metabolic changes
• Pharmacodynamic
– changes in drug-receptor interaction (G-protein uncoupling; down
regulation)
• Conditioning
– automatic physiological change in response to cues
• Motivational
– change in organism’s behavior to attenuate/increase effect
Pharmacodynamics
• Receptor
– target/site of drug action (e.g. genetically-coded proteins embedded
in neural membrane, cytoplasm, nucleus)
– Lock and key model
• Drug acts as key, receptor as lock, combination yields response
Pharmacodynamics continued
• Affinity
– propensity of a drug to bind with a receptor
• Selectivity
– specific affinity for certain receptors (vs. others)
Agonism and Antagonism
Agonists facilitate receptor
response
Antagonists inhibit receptor
response
(direct ant/agonists)
Agonists
• Full Agonist
• Partial Agonist
• Direct/Competitive Agonist
• Indirect/Noncompetitive Agonist
Antagonists
• Direct/Competitive Antagonist
• Indirect/Noncompetitive Antagonist
• Inverse Agonist
Important implications of
drug-receptor interaction
• drugs can potentially alter rate of any bodily/brain function
• drugs cannot impart entirely new functions to cells
• drugs do not create effects, only modify ongoing ones
• drugs can allow for effects outside of normal physiological
range